NFKB1 and metabolic dysfunction-associated steatotic liver disease: Both animal and human studies have proposed that flavonoids exert protective activities against NAFLD by attenuation of nuclear factor kB (NF-kB) signaling, elevation of fatty acid oxidation in liver cells, and improvement of insulin sensitivity [15].